关于我们 Us
Ainnocence is a 全球 biotech company that leads in generative AI for therapeutic discovery, leveraging industry-grade sequence-based proprietary technology and 训练数据 from over 16 years of expertise.
Costly high-throughput wet lab screening, expensive structure biology, and inaccurate 3D modeling processes.
A radical AI drug discovery system accelerating life-saving therapies with unprecedented speed, deep virtual throughput, and higher success rates.
平台演进
从通信动力学理论(2015)到基础模型(2026)
Reality as Information — Physical & biological systems modeled as Shannon communication channels
Polygon error-control / DFT spectral basis
Block-circulant operators
Noise constant κ₀ = CD = 0.0118
📄 Paper I: Pan, Güldal, Baugh & Tanik, SDPS 2015
"Communication Theory Based Mathematical Models for Biomolecular Systems"
📄 Paper II: Pan, Skidmore, Güldal & Tanik, JIDPS 2022
"Application to Modelling the Valence Shell Orbitals of Periodic Table Elements"
📄 Paper III: Pan, L., arXiv:2605.08171, 2026
"Communication Dynamics Neural Networks: FFT-Diagonalized Layers for Improved Hessian Conditioning"
10,000× 计算效率 相比传统量子力学/分子动力学模型
Polygon DFT evaluation bypasses continuous spatial grids
High-dimensional reality compressed into structure-preserving manifolds
分子图 • 反应 • Physico化学 space
AINN-P1 • 基因组 • 蛋白质 • 肽段 • RNA序列空间
研究
Peer-reviewed 研究 spanning AI, drug discovery, and computational biology
Demonstrating the power of sequence-based AI for therapeutic antibody design with unprecedented speed and accuracy.
Three foundational papers spanning biomolecular systems, periodic table orbitals, and neural network 架构
Pan et al. — Mathematical foundation for all Ainnocence 个平台
CarbonAI® platform, ParaVS framework, antibody affinity maturation, and more
14+ additional peer-reviewed publications
知识产权
20+ 项PCT专利 protecting our AI drug discovery methodologies
联系方式